Global Point-of-Care Testing (POCT) Devices Sales Market Report 2022

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Market Analysis and Insights: Global Point-of-Care Testing (POCT) Devices Market

Due to the COVID-19 pandemic, the global Point-of-Care Testing (POCT) Devices market size is estimated to be worth US$ 25670 million in 2021 and is forecast to a readjusted size of US$ 25670 million by 2028 with a CAGR of 9.2% during the review period. Fully considering the economic change by this health crisis, by Product Type accounting for % of the Point-of-Care Testing (POCT) Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Product Type segment is altered to an % CAGR throughout this forecast period.

The United States Point-of-Care Testing (POCT) Devices market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the United States is % in 2021, while Chinese percentage is %, and it is predicted that China’s share will reach % in 2028, trailing a CAGR of % through the analysis period.

The global key manufacturers of Point-of-Care Testing (POCT) Devices include Abbott, Roche Diagnostics, Medtronic, Johnson & Johnson, Siemens Healthineers, Philips, Abaxis (Zoetis), Samsung Healthcare and Beckman Coulter, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

In United States, in terms of revenue, in 2021, the top three players hold a share about %, while in China, top three players hold a share nearly %.

Global Point-of-Care Testing (POCT) Devices Scope and Market Size

The global Point-of-Care Testing (POCT) Devices market is segmented by company, region (country), by Product Type and by Application. Players, stakeholders, and other participants in the global Point-of-Care Testing (POCT) Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Product Type and by Application for the period 2017-2028.

Segment by Product Type

Urinalysis Analyzers

Blood Glucose Meter

Clinical Chemistry Analyzers

Blood Gas Analyzers

INR Test Meter

Cardiac Marker Analyzers

PH Meter

Electrolyte Analyzers

Hemoglobin Meter

Other



Segment by Application


Clinics

Hospitals

Laboratory

Others


By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions



By Company


Abbott

Roche Diagnostics

Medtronic

Johnson & Johnson

Siemens Healthineers

Philips

Abaxis (Zoetis)

Samsung Healthcare

Beckman Coulter

ACON Laboratories

Cardinal Health